Non-profit · founded 1927
Lankenau Institute for Medical Research
Philadelphia, United States · limr.org
- Citations, last 5 years
- 4 951
- Works, last 5 years
- 618
- h-index
- 239
- Scientists listed
- 24
- Grants since 2016
- 45
Grants received
2025–2029 · research · R01
Defining the cellular and molecular mechanism of IDO2 function driving autoimmune vs.protective immune responses
Laura Mandik-Nayak · Lankenau Institute for Medical Research · funded by National Institutes of Health
2025–2027 · research · R21
Development of Mouse Models to Study the Role of Mechanotransduction in Disease Pathogenesis
Glenn Lawrence Radice · Lankenau Institute for Medical Research · funded by National Institutes of Health
2024–2026 · research · R21
Regulation of Mechanical Coupling in Aging Myocardium
Glenn Lawrence Radice · Lankenau Institute for Medical Research · funded by National Institutes of Health
2022–2026 · research · R01
Probing an Unexplored Intracellular Pathway in Diabetes Pathogenesis
George C Prendergast · Lankenau Institute for Medical Research · funded by National Institutes of Health
2022–2025 · research · R01
Probing an Unexplored Intracellular Pathway in Diabetes Pathogenesis
George C Prendergast · Lankenau Institute for Medical Research · funded by National Institutes of Health
2022–2025 · research · R01
Probing an Unexplored Intracellular Pathway in Diabetes Pathogenesis
George C Prendergast · Lankenau Institute for Medical Research · funded by National Institutes of Health
2021–2026 · research · R01
Mechanisms of tumor initiation upon disruption of the Rb/E2f interaction
Patrick Viatour · Lankenau Institute for Medical Research · funded by National Institutes of Health
2021–2026 · research · R01
Mechanisms of tumor initiation upon disruption of the Rb/E2f interaction
Patrick Viatour · Lankenau Institute for Medical Research · funded by National Institutes of Health
2021–2026 · research · R01
Mechanisms of tumor initiation upon disruption of the Rb/E2f interaction
Patrick Viatour · Lankenau Institute for Medical Research · funded by National Institutes of Health
2021–2026 · research · R01
Mechanisms of tumor initiation upon disruption of the Rb/E2f interaction
Patrick Viatour · Lankenau Institute for Medical Research · funded by National Institutes of Health
2021–2027 · research · R01
Mechanisms of tumor initiation upon disruption of the Rb/E2f interaction
Patrick Viatour · Lankenau Institute for Medical Research · funded by National Institutes of Health
2020–2024 · research · R01
Development of a whole heart model of the J wave syndromes and novel approaches to pharmacologic management of associated life-threatening arrhythmias
Charles Antzelevitch · Lankenau Institute for Medical Research · funded by National Institutes of Health
2020–2024 · research · R01
Development of a whole heart model of the J wave syndromes and novel approaches to pharmacologic management of associated life-threatening arrhythmias
Charles Antzelevitch · Lankenau Institute for Medical Research · funded by National Institutes of Health
2020–2025 · research · R01
Development of a whole heart model of the J wave syndromes and novel approaches to pharmacologic management of associated life-threatening arrhythmias
Charles Antzelevitch · Lankenau Institute for Medical Research · funded by National Institutes of Health
2020–2024 · research · R01
Development of a whole heart model of the J wave syndromes and novel approaches to pharmacologic management of associated life-threatening arrhythmias
Charles Antzelevitch · Lankenau Institute for Medical Research · funded by National Institutes of Health
2019–2022 · research · R00
Histone modifications regulating phenotype plasticity: Role of non-canonical Wnt signaling
Marie Ruth Webster · Lankenau Institute for Medical Research · funded by National Institutes of Health
2019–2023 · research · R00
Histone modifications regulating phenotype plasticity: Role of non-canonical Wnt signaling
Marie Ruth Webster · Lankenau Institute for Medical Research · funded by National Institutes of Health
2019–2022 · research · R00
Histone modifications regulating phenotype plasticity: Role of non-canonical Wnt signaling
Marie Ruth Webster · Lankenau Institute for Medical Research · funded by National Institutes of Health
2018–2020 · research · R56
Novel Approaches to Pharmacologic Management of Life-Threatening Arrhythmias Associated with the J Wave Syndromes
Charles Antzelevitch · Lankenau Institute for Medical Research · funded by National Institutes of Health
2017–2019 · research · Global Health
Lankenau Institute for Medical Research - to establish methods to deliver active secretory IgA antibodies (sIgAs) to the intestine, which will be a foundation for safe and cost-effective t...
Lankenau Institute for Medical Research · funded by Bill and Melinda Gates Foundation
2017–2020 · research · R21
New Drug Discovery Paradigms for Synucleinopathies
David R Borchelt · Lankenau Institute for Medical Research · funded by National Institutes of Health
2017–2019 · research · R21
New Drug Discovery Paradigms for Synucleinopathies
David R Borchelt · Lankenau Institute for Medical Research · funded by National Institutes of Health
2016–2019 · research · R21
Comprehensive functional assesment of the human antibody response to Enterovirus 71
Scott Kendall Dessain · Lankenau Institute for Medical Research · funded by National Institutes of Health
2016–2018 · research · R21
Comprehensive functional assesment of the human antibody response to Enterovirus 71
Scott Kendall Dessain · Lankenau Institute for Medical Research · funded by National Institutes of Health
2016–2019 · research · R21
Immunotoxins based on the IgG response to autologous antigens in cancer patients
Scott Kendall Dessain · Lankenau Institute for Medical Research · funded by National Institutes of Health
2016–2018 · research · R21
Immunotoxins based on the IgG response to autologous antigens in cancer patients
Scott Kendall Dessain · Lankenau Institute for Medical Research · funded by National Institutes of Health
2015–2020 · research · R01
Polyamine-stimulated stem cell recruitment in arsenic-induced skin cancer
Susan K. Gilmour · Lankenau Institute for Medical Research · funded by National Institutes of Health
2015–2020 · research · R01
Polyamine-stimulated stem cell recruitment in arsenic-induced skin cancer
Susan K. Gilmour · Lankenau Institute for Medical Research · funded by National Institutes of Health
2015–2020 · research · R01
IDO2 Targeting in Pancreatic Cancer
George C Prendergast · Lankenau Institute for Medical Research · funded by National Institutes of Health
2015–2021 · research · R01
Polyamine-stimulated stem cell recruitment in arsenic-induced skin cancer
Susan K. Gilmour · Lankenau Institute for Medical Research · funded by National Institutes of Health
2015–2020 · research · R01
IDO2 Targeting in Pancreatic Cancer
George C Prendergast · Lankenau Institute for Medical Research · funded by National Institutes of Health
2015–2020 · research · R01
Polyamine-stimulated stem cell recruitment in arsenic-induced skin cancer
Susan K. Gilmour · Lankenau Institute for Medical Research · funded by National Institutes of Health
2015–2020 · research · R01
IDO2 Targeting in Pancreatic Cancer
George C Prendergast · Lankenau Institute for Medical Research · funded by National Institutes of Health
2015–2020 · research · R01
Polyamine-stimulated stem cell recruitment in arsenic-induced skin cancer
Susan K. Gilmour · Lankenau Institute for Medical Research · funded by National Institutes of Health
2015–2020 · research · R01
IDO2 Targeting in Pancreatic Cancer
George C Prendergast · Lankenau Institute for Medical Research · funded by National Institutes of Health
2015–2020 · research · R01
IDO2 Targeting in Pancreatic Cancer
George C Prendergast · Lankenau Institute for Medical Research · funded by National Institutes of Health
2014–2020 · cooperative agreement · UG1
NCI Community Oncology Research Program (NCORP) Community Sites
Albert Denittis · Lankenau Institute for Medical Research · funded by National Institutes of Health
2011–2022 · research · R01
A new model of regenerative healing via inflammation-modulating biomaterials
Georgios Hajishengallis · Lankenau Institute for Medical Research · funded by National Institutes of Health
2011–2027 · research · R01
New upstream targets for HIF-1a-mediated regeneration in young and aged animals
Georgios Hajishengallis · Lankenau Institute for Medical Research · funded by National Institutes of Health
2011–2022 · research · R01
A new model of regenerative healing via inflammation-modulating biomaterials
Georgios Hajishengallis · Lankenau Institute for Medical Research · funded by National Institutes of Health
